Key facts
- FDA cleared Clarius Mobile Health's AI tool for cardiac ultrasound.
- The AI tool automates Left Ventricular Ejection Fraction (LVEF) calculation.
- LVEF is a key indicator of heart pumping efficiency.
- The tool is integrated into the Clarius App.
- It aims to remove subjectivity and accelerate diagnosis at the point of care.
Clarius Mobile Health has received FDA clearance for its new AI tool, designed to enhance cardiac ultrasound assessments. Integrated into the Clarius App, this tool automates the calculation of Left Ventricular Ejection Fraction (LVEF), a critical measure of heart function. By providing objective, real-time data, the AI aims to improve diagnostic speed and accuracy, particularly in primary care and emergency medicine settings where rapid assessment is crucial.